REPL
Replimune Group Inc
Price:  
5.88 
USD
Volume:  
6,301,909.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

REPL Relative Valuation

-1177.9%
Upside

As of 2026-04-09, the Relative Valuation of Replimune Group Inc (REPL) is (63.44) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.88 USD, the upside of Replimune Group Inc based on Relative Valuation is -1177.9%.

The range of the Relative Valuation is (58.00) - (66.52) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 20.1x - 25.3x 22.6x
Forward P/E multiples 20.2x - 23.1x 21.6x
Fair Price (58.00) - (66.52) (63.44)
Upside -1085.6% - -1230.3% -1177.9%
5.88 USD
Stock Price
(63.44) USD
Fair Price

REPL Relative Valuation - Historical P/E Data

Date P/E
2026-04-06 -2.97
2026-04-02 -2.92
2026-04-01 -2.65
2026-03-31 -2.66
2026-03-30 -2.50
2026-03-27 -2.51
2026-03-26 -2.62
2026-03-25 -2.63
2026-03-24 -2.42
2026-03-23 -2.43
2026-03-20 -2.43
2026-03-19 -2.39
2026-03-18 -2.35
2026-03-17 -2.43
2026-03-16 -2.56
2026-03-13 -2.48
2026-03-12 -2.63
2026-03-11 -2.75
2026-03-10 -2.86
2026-03-09 -3.00
2026-03-06 -2.81
2026-03-05 -2.45
2026-03-04 -2.52
2026-03-03 -2.49
2026-03-02 -2.49
2026-02-27 -2.66
2026-02-26 -2.67
2026-02-25 -2.85
2026-02-24 -2.91
2026-02-23 -2.92
2026-02-20 -3.00
2026-02-19 -2.97
2026-02-18 -2.79
2026-02-17 -2.52
2026-02-13 -2.77
2026-02-12 -2.77
2026-02-11 -2.70
2026-02-10 -2.71
2026-02-09 -2.70
2026-02-06 -2.69
2026-02-05 -2.41
2026-02-04 -2.43
2026-02-03 -2.57
2026-02-02 -2.42
2026-01-30 -2.44
2026-01-29 -2.57
2026-01-28 -2.56
2026-01-27 -2.62
2026-01-26 -2.63
2026-01-23 -2.68